Dr. Jurgi Camblong is a visionary entrepreneur who is pioneering the data-driven medicine movement around the world. He is a molecular biologist (published in Cell, Science and Nature), has a Ph.D. in life sciences from the University of Geneva and an EMBA in management of technology from EPFL/HEC Lausanne. In 2011, he founded SOPHiA GENETICS with Dr. Pierre Hutter and Prof. Lars Steinmetz. Dr. Camblong has since successfully led the development of the company, listed among the 50 Smartest Companies by the MIT Technology Review.